thinklab
  • Influencers
  • About
  • Join
3
Rhythm Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Clinical Trials Evaluating Setmelanotide in POMC and LEPR Deficiency Obesities
GlobeNewswire News Room 125d 1 tweets


Benjamin Voight 125d ago
I mean, I'm not surprised (given the target, MC4R), but holy christ the data for Setmelanotide looks really really promising.
0
About Thinklab
Community values

Follow us


Privacy | © 2019 Thinklab